Merck, Novo Nordisk spared from 1,500 suits over diabetes drug blamed for cancer
Novo Nordisk has been let off the hook in multiple lawsuits brought forth by diabetes patients in the US, alleging cancer links with some of Novo’s and also Merck’s diabetes treatments.
By Jef Feeley, bloomberg
Consumers suing Merck & Co., Novo Nordisk A/S and other makers of diabetes drugs allegedly linked to pancreatic cancer are dropping their complaints, according to an email seen by Bloomberg.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
US legal appeal rejected in win for Novo Nordisk
For subscribers
.jpg&w=384&q=75)
